These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 4437624)

  • 1. Lymphocyte cytotoxicity to isolated hepatocytes in chronic active hepatitis.
    Thomson AD; Cochrane MA; McFarlane IG; Eddleston AL; Williams R
    Nature; 1974 Dec; 252(5485):721-2. PubMed ID: 4437624
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytotoxicity to isolated rabbit hepatocytes by lymphocytes from children with liver disease.
    Smith AL; Cochran AM; Mowat AP; Eddleston AL; Williams R
    J Pediatr; 1977 Oct; 91(4):584-9. PubMed ID: 908978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte cytotoxicity to isolated hepatocytes in chronic active hepatitis. The role of T- and B-cells.
    Eddleston AL
    Tijdschr Gastroenterol; 1975; 18(6):359-66. PubMed ID: 1083570
    [No Abstract]   [Full Text] [Related]  

  • 4. Lymphocyte cytotoxicity for isolated hepatocytes in acute viral and chronic active hepatitis.
    Cochrane M; Eddleston A; Williams R
    Minerva Med; 1978 Aug; 69(38):2543-8. PubMed ID: 714256
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibody-dependent cell-mediated (K cell) cytotoxicity against isolated hepatocytes in chronic active hepatitis.
    Cochrane AM; Moussouros A; Thomsom AD; Eddleston AL; Wiiliams R
    Lancet; 1976 Feb; 1(7957):441-4. PubMed ID: 55716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological studies in patients with chronic active hepatitis. Cytotoxic activity of lymphocytes to autochthonous liver cells grown in tissue culture.
    Paronetto F; Vernace S
    Clin Exp Immunol; 1975 Jan; 19(1):99-104. PubMed ID: 1204242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 51Cr-labeled human hepatocytes as target cells for cytotoxicity mediated by freshly isolated liver-infiltrating lymphocytes.
    Shimizu Y; Hata K; Herberman RB; Whiteside TL
    J Immunol Methods; 1993 Aug; 164(1):69-77. PubMed ID: 8360510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-mediated immunity in liver disease.
    Paronetto F
    Hum Pathol; 1986 Feb; 17(2):168-78. PubMed ID: 3512412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte cytotoxicity for isolated hepatocytes in alcoholic liver disease.
    Cochrane AM; Moussouros A; Portmann B; McFarlane IG; Thomson AD; Eddleston ; Williams R
    Gastroenterology; 1977 May; 72(5 Pt 1):918-23. PubMed ID: 300342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte damage induced by lymphocytes from patients with chronic liver diseases, as detected by LDH release.
    Fernandez-Cruz E; Escartin P; Bootello A; Kreisler M; Segovia de Arana JM
    Clin Exp Immunol; 1978 Mar; 31(3):436-42. PubMed ID: 657588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic aspects of liver disease.
    Kanagasundaram N; Leevy CM
    Med Clin North Am; 1979 May; 63(3):631-42. PubMed ID: 376975
    [No Abstract]   [Full Text] [Related]  

  • 12. K-cell-mediated antibody-dependent cellular cytotoxicity in chronic active liver disease.
    Kawanishi H; MacDermott RP
    Gastroenterology; 1979 Jan; 76(1):151-8. PubMed ID: 361492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis.
    Eggink HF; Houthoff HJ; Huitema S; Gips CH; Poppema S
    Clin Exp Immunol; 1982 Oct; 50(1):17-24. PubMed ID: 6983407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte cytotoxicity and inhibition studied with autologous liver cells: observations in chronic active liver disease and the primary biliary cirrhosis syndrome.
    Geubel AP; Keller RH; Summerskill WH; Dickson ER; Tomasi TB; Shorter RG
    Gastroenterology; 1976 Sep; 71(3):450-6. PubMed ID: 950096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lymphocyte subset cytotoxic to cultured rat hepatocytes in patients with chronic active hepatitis and healthy subjects (author's transl)].
    Nonomura A; Haratake J; Karino T; Ohta G
    Nihon Shokakibyo Gakkai Zasshi; 1980 Feb; 77(2):214-20. PubMed ID: 7401357
    [No Abstract]   [Full Text] [Related]  

  • 16. Proceedings: Lymphocyte mediated cytotoxicity for Chang liver cells in acute and chronic liver disease.
    Jacques E; De Villers D; Thomas HC; Sherlock S
    Gut; 1976 May; 17(5):389. PubMed ID: 1278737
    [No Abstract]   [Full Text] [Related]  

  • 17. Lymphocyte cytotoxicity for autologous hepatocytes.
    Mondelli M; Eddleston AL
    Gut; 1984 Feb; 25(2):109-13. PubMed ID: 6607192
    [No Abstract]   [Full Text] [Related]  

  • 18. Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis.
    Eddleston AL; Williams R
    Lancet; 1974 Dec; 2(7896):1543-5. PubMed ID: 4140983
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunological factors in the evolution of active chronic hepatitis and other autoimmune liver diseases.
    Smith MG; Eddleston AL; Williams R
    Clin Gastroenterol; 1975 May; 4(2):297-313. PubMed ID: 1092487
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanisms responsible for antibody-dependent, cell-mediated cytotoxicity to isolated hepatocytes in chronic active hepatitis.
    Gonzales C; Cochrane AM; Eddleston AL; Williams R
    Gut; 1979 May; 20(5):385-8. PubMed ID: 572801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.